All News

In part 2 of the Pharmacy Times® Pharmacy Face-Off Gameshow™, pharmacy students from the University of the Sciences Philadelphia College of Pharmacy and the Rutgers University Ernest Mario School of Pharmacy entered a lightning round with clinical questions.

We see today far more clearly the impact of health care inequality, which can directly affect patient access to care, specifically oncologic care.

There is more to patients with IBD than the physical detriments, with many mental health issues arising from the condition.

New CDC guidelines based on four decades of safety, immunogenicity, and efficacy data on the HBV vaccine, but with suboptimal coverage in the United States.

Ted Okon, MBA, executive director of the Community Oncology Alliance (COA), discusses key highlights from the in-person COA 2022 conference.

Ganciclovir ophthalmic gel (Zirgan) is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers).

Calamine spray treats insect bites, rashes, minor skin irritations, and minor cuts.

Pharmacy Times® parent company is hosting the virtual MJH Life Sciences Sleeves Up Blood Drive from March 31 through April 30.

These include progression-free survival, time to treatment failure, and time to tumor progression, according to a presentation at the Hematology/Oncology Pharmacy Association conference.

21-gene profiling is also preferred for patients with 1 to 3 pathologically positive lymph nodes, according to a presentation at the Hematology/Oncology Pharmacy Association conference.

Measurements may not be accurate in those with darker tones, according to analysis to be presented at the American College of Cardiology’s 71st Annual Scientific Session.

Pharmacy managers can cultivate an innovative mindset amongst staff members by adopting an attitude that is welcoming to change.

How would you handle these patients' questions?

Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.

Christy S. Harris, PharmD, BCOP, FHOPA, clinical pharmacy specialist at Dana-Farber Cancer Institute, discusses guidelines for common therapies and appropriate monitoring recommendations for selected therapies used in the treatment of adult sarcomas.

Deucravacitinib is a possible solution for patients with psoriasis who wish to have the convenience of an oral medication.

Vimala Raghavendran, MBA, head of the Pharmaceutical Supply Chain Center at US Pharmacopeia (USP), explains how pharmacists can get involved in USP’s Medicine Supply Vulnerability Insights Series assessing global pharmaceutical supply chain vulnerabilities.

Triumeq is a tablet containing 50 mg of dolutegravir, 600 mg of abacavir, and 300 mg of lamivudine.

This month's product news features PMS gummy vitamins, a prebiotic acne therapy, and apple cider vinegar supplements.

Heidi D. Finnes, PharmD, BCOP, FHOPA, president-elect of Hematology/Oncology Pharmacy Association (HOPA), discusses ways to address burnout in the hematology/oncology space.

Golytely is indicated for cleansing of the colon in preparation for colonoscopy and barium enema X-ray examination in adults.

Purelax aids in the treatment of occasional constipation and irregularity.

FDA to evaluate New Drug Application for futibatinib in the treatment of patients with previously treated locally advanced or metastatic cholangiocarcinoma.

The Roche subsidiary reports that it will continue to evaluate tiragolumab plus Tecentriq and chemotherapy in non-small cell lung cancer and other cancer types through more phase 3 trials.

Brought to you by the Sassy Pharmacist

Heidi D. Finnes, PharmD, BCOP, FHOPA, president-elect of Hematology/Oncology Pharmacy Association (HOPA), provides details of the upcoming HOPA 2022 conference.

ImmunoGen, Inc submits Biologics License Application under the accelerated approval pathway for mirvetuximab soravtansine monotherapy for patients with FRα-high platinum-resistant ovarian cancer previously treated with 1 to 3 prior systemic treatments.

They are also at greater risk of death than men when undergoing cardiac procedures, a new analysis shows.